PMGC Holdings (ELAB) EBT (2022 - 2026)
PMGC Holdings (ELAB) posted EBT of -$6.1 million for Q1 2026, down 126.15% sequentially from -$2.7 million in Q4 2025, and down 5547.52% YoY from $111377.0 in Q1 2025.
PMGC Holdings (ELAB) EBT (2022 - 2026) Analysis & Trends
PMGC Holdings has reported EBT for 5 years, with the latest figure at -$6.1 million in Q1 2026.
- Quarterly EBT fell 5547.52% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.1 million (down 652.14% YoY) and the FY2025 annual result came in at $8.4 million, up 38.06% from the prior year.
- EBT declined to -$6.1 million in Q1 2026 per ELAB's latest filing, from -$2.7 million in the prior quarter.
- Over five years, EBT peaked at $1.1 billion in Q4 2022 and troughed at -$469.3 million in Q3 2022.
- A 5-year average of $23.8 million and a median of -$1.6 million in 2024 frame the typical range for EBT.
- The sharpest annual moves came in 2024 and 2026: EBT surged 233.59% in 2024, then plunged 5547.52% in 2026.
- Over 5 years, EBT stood at $1.1 billion in 2022, then sank by 100.1% to -$1.1 million in 2023, then soared by 233.59% to $1.4 million in 2024, then sank by 285.51% to -$2.7 million in 2025, then slumped by 126.15% to -$6.1 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$6.1 million, -$2.7 million, and -$3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | PMGC Holdings | 3.01 Mn | -15.78 Mn | 385,691.00 | -4.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.07 Mn |
| Dec 31, 2025 | -2.68 Mn |
| Sep 30, 2025 | -3.31 Mn |
| Jun 30, 2025 | -2.00 |
| Mar 31, 2025 | 111,377.00 |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | -1.60 Mn |
| Jun 30, 2024 | -1.56 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | -270.32 Mn |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -843,918.00 |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | -469.32 Mn |